MeSH tree: F03.615.250
Schizophrenia affects approximately 23 million people worldwide, with onset usually occurring during a person's late adolescence or 20s. Impairments associated with schizophrenia include hallucinations, delusions, and disorganized ...
11 hours ago
0
4
New genetic risk factors have been identified for fibromyalgia syndrome in a landmark study that involved scientists at King's College London. The study, published in Nature Medicine, highlights how the nervous system plays ...
Jul 28, 2026
0
34
Today, most older people with disabilities receive help at home, and there are limited places in nursing homes. At the same time, politicians claim that living at home provides independence and control over everyday life.
Jul 21, 2026
0
23
Nicotinamide adenine dinucleotide, or NAD+, is all the rage in the healthy aging space. Social media influencers tout NAD+ supplements, injections and infusions as anti-aging miracles that can clear brain fog and improve ...
Jul 21, 2026
0
9
Nearly half the world's population experiences menopause, yet many of its emotional, cognitive and social impacts may never be discussed during medical appointments. New research published today in JAMA Network Open, led ...
Jul 15, 2026
0
8
Up to 45 percent of dementia risk could be prevented or delayed, the World Health Organization said Wednesday, citing modifiable risk factors such as tobacco use and air pollution.
Jul 15, 2026
0
3
A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers reported Wednesday.
Jul 15, 2026
0
6
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual ...
Jul 15, 2026
0
20
The same lifestyle choices that reduce your risk of heart disease, diabetes and cancer can also reduce your risk of cognitive decline. Bryan Woodruff, M.D., a cognitive neurologist at Mayo Clinic in Arizona, explains the ...
Jul 9, 2026
0
23
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents ...
Jul 9, 2026
0
4
